Evergreen Animal Hospital
Specialty hospital / research center
2 current cancer treatment or research opportunities
About Evergreen Animal Hospital
Evergreen Animal Hospital in Taiwan provides companion-animal care and has an active clinical-research program for dogs with cancer. The hospital works with outside research teams so screening, treatment and follow-up can be performed in a regular veterinary setting.
Evergreen clinical-trial notice →
Who the current listings are forDogs
Cancer types currently listedOral Melanoma, Osteosarcoma
Where visits take placeEvergreen Animal Hospital, No. 78 Guangzhou St, Wanhua Dist, Taipei City, Taiwan
Current options at Evergreen Animal Hospital
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
IL-15 immunotherapy for canine melanoma or osteosarcoma with pulmonary metastasis
Evergreen Animal Hospital (長青動物醫院), Taipei · Taiwan
Recruiting
What is being offered: Official hospital recruitment page. Cytology- or histopathology-confirmed melanoma or osteosarcoma; breed, age, weight and sex unrestricted. Requires pulmonary metastatic lesion >1.0 cm and no life-threatening tumor-related symptoms. Current steroids or other immunosuppressants are not allowed. Owner must attend weekly treatment/follow-up for about 10-12 weeks. IL-15 is given weekly for 8 treatments, by subcutaneous injection and, for pulmonary metastatic disease, also via nebulized inhalation. IL-15 drug is free; diagnostics and supportive medications are owner-paid. IMPORTANT matcher prescreen: official protocol specifically requires a lung metastatic lesion >1.0 cm; current schema cannot encode the 1-cm pulmonary-lesion threshold separately, so final eligibility must confirm this criterion.
Who may qualify: Confirmed cancer diagnosis required; Metastatic; Measurable; Measurable lung metastases; Pulmonary lesion cm exclusive: 1
May not qualify if: Current steroids; Immunosuppressive
Costs / coverage: 🟡 Partially funded. The IL-15 study drug is provided at no charge; owners pay for required tests and supportive medications during treatment.
Contact: Evergreen Animal Hospital main hospital oncology clinic, Taipei; phone 02-23369908. Ask for IL15臨床試驗.
Location
- Evergreen Animal Hospital, No. 78 Guangzhou St, Wanhua Dist, Taipei City, Taiwan
Official study / enrollment information →
PT001 PD-L1/CTLA-4 recombinant protein therapeutic vaccine for stage II-III canine oral malignant melanoma
Protect Animal Health (寶泰生醫) multicenter field trial · Taiwan
Recruiting — multicenter field trial
What is being offered: Official sponsor recruitment notice dated 2025-10-26 remains publicly listed; sponsor subsequently announced regulatory approval to conduct the Taiwan field trial on 2025-11-03 and continues to describe PT001 as an active oncology development program in 2026. Multicenter randomized open-label two-arm field trial of PT001, a PD-L1 and CTLA-4 recombinant-protein therapeutic vaccine, for confirmed stage II-III canine oral malignant melanoma. Age >=1 year. Owners must agree to suspend other cancer treatment. Excludes severe liver/kidney disease, autoimmune disease, bone-marrow disease or other high-risk systemic disease, dogs requiring steroids/immunosuppressants, and prior radiation. Tumor must be recordable/measurable. Trial contains a control arm. Final screening by study site is required.
Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Measurable; Oral melanoma stage ii or iii; Other treatments suspended
May not qualify if: Prior local radiation; Current steroids; Immunosuppressive
Costs / coverage: The current protocol page does not state which treatment, testing or follow-up costs are covered; confirm directly with the study team.
Contact: Participating veterinary hospitals listed on the official recruitment page; screening through the study sites.
Location
- Evergreen Animal Hospital, No. 78 Guangzhou St, Wanhua Dist, Taipei City, Taiwan
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
